T-Cell Therapy Market To Surpass USD 17.3 Billion By 2027 At A CAGR Of 20.9%
The report analyzes and forecasts the T-Cell Therapy Market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2022 to 2030. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global T-Cell Therapy Market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the T-Cell Therapy Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of T-Cell Therapy Market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Download Sample Report Copy From Here:https://www.acumenresearchandconsulting.com/request-sample/2494
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report. Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding. Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
Market Players as below:
Players operating in the global T-cell therapy market are Novartis AG, Merck KGaA, Gilead Sciences Inc., TCR2 Therapeutics Inc., Bluebird Bio Inc., Sorrento Therapeutics, Fate Therapeutics, Pfizer Inc., and Amgen.
The major market segments of T-Cell Therapy Market are as below:
Market By Modality
Research
Commercialized
Market By Therapy Type
CAR T-cell Therapy
T-Cell Receptor (TCR)-based
Tumor Infiltrating Lymphocytes (TIL)-based
Market By Indication
Hematologic Malignancies
• Lymphoma
• Leukemia
• Myeloma
Solid Tumors
• Melanoma
• Brain & Central Nervous System
• Liver Cancer
• Others
Ask Query Here: richard@acumenresearchandconsulting.com or sales@acumenresearchandconsulting.com
Table Of Contents:
CHAPTER 1. Industry Overview of T-cell Therapy
1.1. Definition and Scope
1.1.1. Definition of T-cell Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global T-cell Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. T-cell Therapy Market By Modality
1.2.3. T-cell Therapy Market By Therapy Type
1.2.4. T-cell Therapy Market By Indication
1.2.5. T-cell Therapy Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of T-cell Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for T-cell Therapy Market
3.7. Value Chain Analysis
3.8. Cost Structure Analysis
3.8.1. Proportion of Manufacturing Cost Structure
3.8.1.1. Raw Material
3.8.1.2. Labor Cost
3.8.1.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2019
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2019
4.2. R&D Status and Application Source of T-cell Therapy Major Manufacturers in 2019
CHAPTER 5. T-cell Therapy Market By Modality
5.1. Introduction
5.2. T-cell Therapy Revenue By Modality
5.2.1. T-cell Therapy Revenue (US$ Mn) and Forecast, By Modality, 2016-2027
5.2.2. Research
5.2.2.1. Research Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Commercialized
5.2.3.1. Commercialized Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. T-cell Therapy Market Revenue By Therapy Type
6.1. Introduction
6.2. T-cell Therapy Revenue (US$ Mn) By Therapy Type
6.2.1. T-cell Therapy Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
6.2.2. CAR T-cell Therapy
6.2.2.1. CAR T-cell Therapy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. T Cell Receptor (TCR)-based
6.2.3.1. T Cell Receptor (TCR)-based Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Tumor Infiltrating Lymphocytes (TIL)-based
6.2.4.1. Tumor Infiltrating Lymphocytes (TIL)-based Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. T-cell Therapy Market By Indication
7.1. Introduction
7.2. T-cell Therapy Revenue (US$ Mn) By Indication
7.2.1. T-cell Therapy Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
7.2.2. Hematologic Malignancies
7.2.2.1. Hematologic Malignancies Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.2.2. Lymphoma
7.2.2.3. Leukemia
7.2.2.4. Myeloma
7.2.3. Solid Tumors
7.2.3.1. Solid Tumors Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
7.2.3.2. Melanoma
7.2.3.3. Brain & Central Nervous System
7.2.3.4. Liver Cancer
7.2.3.5. Others
7.2.4. Others
7.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 8. North America T-cell Therapy Market By Country
8.1. North America T-cell Therapy Overview
8.2. U.S.
8.2.1. U.S. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
8.2.2. U.S. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
8.2.3. U.S. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
8.3. Canada
8.3.1. Canada T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
8.3.2. Canada T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
8.3.3. Canada T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
8.4. North America PEST Analysis
CHAPTER 9. Europe T-cell Therapy Market By Country
9.1. Europe T-cell Therapy Market Overview
9.2. U.K.
9.2.1. U.K. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.2.2. U.K. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.2.3. U.K. T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.3. Germany
9.3.1. Germany T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.3.2. Germany T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.3.3. Germany T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.4. France
9.4.1. France T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.4.2. France T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.4.3. France T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.5. Spain
9.5.1. Spain T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.5.2. Spain T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.5.3. Spain T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.6. Rest of Europe
9.6.1. Rest of Europe T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016-2027
9.6.2. Rest of Europe T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016-2027
9.6.3. Rest of Europe T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016-2027
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific T-cell Therapy Market By Country
10.1. Asia Pacific T-cell Therapy Market Overview
10.2. China
10.2.1. China T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.2.2. China T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.2.3. China T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.3. Japan
10.3.1. Japan T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.3.2. Japan T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.3.3. Japan T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.4. India
10.4.1. India T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.4.2. India T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.4.3. India T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.5. Australia
10.5.1. Australia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.5.2. Australia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.5.3. Australia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.6. South Korea
10.6.1. South Korea T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.6.2. South Korea T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.6.3. South Korea T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
10.7.2. Rest of Asia-Pacific T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
10.7.3. Rest of Asia-Pacific T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America T-cell Therapy Market By Country
11.1. Latin America T-cell Therapy Market Overview
11.2. Brazil
11.2.1. Brazil T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
11.2.2. Brazil T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
11.2.3. Brazil T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
11.3. Mexico
11.3.1. Mexico T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
11.3.2. Mexico T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
11.3.3. Mexico T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
11.4. Rest of Latin America
11.4.1. Rest of Latin America T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
11.4.2. Rest of Latin America T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
CHAPTER 12. Middle East & Africa T-cell Therapy Market By Country
12.1. Middle East & Africa T-cell Therapy Market Overview
12.2. Saudi Arabia
12.2.1. Saudi Arabia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
12.2.2. Saudi Arabia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
12.2.3. Saudi Arabia T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
12.3. UAE
12.3.1. UAE T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
12.3.2. UAE T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
12.3.3. UAE T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa T-cell Therapy Market Revenue (US$ Mn) and Forecast By Modality, 2016 – 2027
12.4.2. Rest of Middle East & Africa T-cell Therapy Market Revenue (US$ Mn) and Forecast By Therapy Type, 2016 – 2027
12.4.3. Rest of Middle East & Africa T-cell Therapy Market Revenue (US$ Mn) and Forecast By Indication , 2016 – 2027
CHAPTER 13. PLAYER ANALYSIS OF T-CELL THERAPY
13.1. T-cell Therapy Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global T-cell Therapy Market
CHAPTER 14. COMPANY PROFILE
14.1. Novartis AG
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Mn), 2019
14.1.3.2. Novartis AG 2019 T-cell Therapy Business Regional Distribution
14.1.4. Product/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Merck KGaA
14.3. Gilead Sciences Inc.
14.4. TCR2 Therapeutics Inc
14.5. Bluebird Bio Inc.
14.6. Sorrento Therapeutics
14.7. Fate Therapeutics
14.8. Pfizer Inc.
14.9. Amgen
14.10. Celgene Corporation
14.11. Others
To Get Premium Report Full Copy in Form of Single user or Multiple user@https://www.acumenresearchandconsulting.com/buy-now/0/2494
About Us:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.
